HCA Healthcare said on Tuesday, February 20, 2024, that it and its wholly owned subsidiary HCA Inc. entered into an underwriting agreement with BofA Securities, Barclays, Citigroup Global Markets and J.P. Morgan Securities as representatives of the underwriters. Under the agreement, HCA Inc. will issue and sell senior notes totaling $4,500,000,000.

1. 01

   HCA Healthcare said on Tuesday, February 20, 2024, that it and its wholly owned subsidiary HCA Inc. entered into an underwriting agreement with BofA Securities, Barclays, Citigroup Global Markets and J.P. Morgan Securities as representatives of the underwriters. Under the agreement, HCA Inc. will issue and sell senior notes totaling $4,500,000,000.

2. 02

   The company said the senior notes include $1,000,000,000 of 5.450% notes due 2031 and $1,300,000,000 of 5.600% notes due 2034.

3. 03

   The company said the senior notes also include $1,500,000,000 of 6.000% notes due 2054 and $700,000,000 of 6.100% notes due 2064.

4. 04

   The company said the notes will be guaranteed on a senior unsecured basis by parent company HCA Healthcare and will be issued and sold under Form S-3 registration statement (File No. 333-271537) and a preliminary prospectus supplement dated February 20, 2024.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.